Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Exisulind for Prostate Cancer Recurrence
NCT00166426Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2003
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exisulind in prostate cancer (PCa), sponsored by Mayo Clinic. Started Feb 2003; status: completed.
02
Drugs
exisulind
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00166426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166426.